Page 93 - IJB-9-4
P. 93

International Journal of Bioprinting                                       Laser transfer for CTC isolation





























            Figure 8. Isolated CTC proliferation assay. MDA-MB-231 were cultured in a 96-well plate with RPMI culture media enriched with FBS (10%) and
                           [78]
              acclimated media (10%) . One microliter of control cells was taken from the sample prior to the laser isolation and cultured in the same conditions.
            Dimension bar represents 100 µm.
























            Figure 9. Complete enrichment-identification-isolation workflow. The proposed approach follows a standard enrichment-identification-isolation process
            but due to the negative selection and laser transfer using a BA-LIFT approach, the CTCs remain completely unaltered.

            Acknowledgments                                    Incyte, Servier, Lilly, Roche, and Daiichi Sankyo; is in
                                                               the Speakers’ Bureau of  Rovi, Stada, Menarini, Bayer,
            None.
                                                               Merck Serono, Amgen, Lilly, Astra Zeneca, Sanofi, BMS,
            Funding                                            Pfizer, and Daiichi Sankyo; and has been sponsored
                                                               by Roche, Amgen, Merck Serono, Celgene, and Astra
            This work was partially supported by Comunidad de   Zeneca to cover expenses in travel and accommodations.
            Madrid Government/Fondo Social Europeo , S2018/BAA-  Sara Lopez-Tarruella has a consulting or advisory role
            4480, Biopieltec-CM, and Spanish Ministry for Education   at AstraZeneca, Novartis, Roche, Pfizer, Pierre Fabre,
            FPU Grant 2015/05605.                              Lilly, Seagen,  Daiichi Sankyo, Gilead  Sciences,  MSD,
                                                               GlaxoSmithKline and Veracity; and is in the Speakers’
            Conflict of interest                               Bureau of Lilly. Miguel Martin has a consulting or
            Andres Muñoz has a consulting or advisory role at Sanofi,   advisory role at Roche/Genentech, Novartis, Pfizer, Lilly,
            Celgene, Pfizer, BMS, Leo Pharma, Astra Zeneca, MSD,   AstraZeneca, Taiho Pharmaceutical, and PharmaMar; is in


            Volume 9 Issue 4 (2023)                         85                         https://doi.org/10.18063/ijb.720
   88   89   90   91   92   93   94   95   96   97   98